TABLE 2.
Mouse lineb | Mean no. of cells (10−6) ± SD in different subpopulations
|
Mean CD4/CD8 ratio ± SD | Mean fluorescence (%) ± SDc
|
||||
---|---|---|---|---|---|---|---|
Total | CD4+ | CD8+ | TcR | CD4 | CD8 | ||
Non-Tg | 17.4 ± 5.2 | 9.0 ± 2.5 | 3.8 ± 1.9 | 13.0 ± 4.8* | 2.5 ± 0.5* | 100 | 100 |
CD4C/HIVNef | 5.8 ± 3.9* | 0.9 ± 0.6* | 1.4 ± 1* | 2.1 ± 1.5* | 0.6 ± 0.1* | 15 ± 9* | 80 ± 20 |
mCD4/HIVNef | |||||||
F85838 | 3.9 ± 1.8* | 0.6 ± 0.3* | 1.0 ± 0.5* | 1.6 ± 0.8* | 0.5 ± 0.1* | 30 ± 5* | 95 ± 5 |
F85840 | 3.3 ± 0.7* | 0.3 ± 0.1* | 0.9 ± 0.4* | 1.4 ± 0.5* | 0.5 ± 0.2* | 21 ± 13* | 92 ± 2 |
CD4F/HIVNef | |||||||
F78558 | 3.8 ± 1.4* | 1.1 ± 0.4* | 1.2 ± 0.4* | 2.3 ± 0.9* | 0.9 ± 0.1* | 16 ± 3* | 90 ± 10 |
F95136 | 6.0 ± 3.5* | 0.8 ± 0.7* | 1.7 ± 0.1* | 2.7 ± 1.8* | 0.4 ± 0.2* | 21 ± 9* | 97 ± 7 |
CD4E/HIVNef | |||||||
F104990 | 3.6 ± 0.9* | 0.7 ± 0.2* | 0.9 ± 0.2* | 1.6 ± 0.4* | 0.8 ± 0.1* | 26 ± 8* | 75 ± 11* |
F104991 | 6.8 ± 0.3* | 1.1 ± 0.4* | 1.2 ± 0.1* | 2.1 ± 0.3* | 0.9 ± 0.4* | 28 ± 20* | 70 ± 2* |
CD68/HIVNef | |||||||
F115708 | 11.1 ± 1.1* | 5.7 ± 0.3* | 2.2 ± 0.2 | 8 ± 0.5* | 2.5 ± 0.2 | 93 | 91 |
F115709 | 12.8 ± 5 | 6.1 ± 2.1 | 3.1 ± 1.4 | 6.9 ± 5 | 2 ± 0.1 | 100 | 90 |
CD11c | |||||||
F98506 | 15 ± 6.2 | 8.4 ± 4.3 | 3.2 ± 1.4 | 11.6 ± 5.6 | 2.5 ± 0.4 | 100 | 100 |
F98507 | 10.8 ± 1.7* | 5.9 ± 1.0* | 2.1 ± 0.6 | 8.1 ± 1.6* | 2.8 ± 0.3 | 100 | 100 |
*, P < 0.05 according to the Student's t test, comparing Tg with non-Tg growth.
FACS analysis was performed on four to nine mice (1.5 to 3 months old) for each Tg line, except for CD4F/HIVNef (F95136) and CD68/HIVNef mice (both founders), which were analyzed at 2 to 4 months of age. The non-Tg control values were obtained by pooling the results of all non-Tg littermates from different lines.
The mean fluorescence values for CD4 and CD8 T cells were obtained by calculating the ratio of Tg CD4 or CD8 relative to that of non-Tg lymph nodes (100%). Mean values were then calculated with the values for each line.